Klaria Pharma Holding AB (KLAR) — Capital Reinvestment Ratio

Latest as of March 2020: 0.07x

Klaria Pharma Holding AB (KLAR) has a Capital Reinvestment Ratio of 0.07x as of March 2020, meaning it reinvests 0% of its operating cash flow (Skr442.00K) in capital expenditures (Skr33.00K). Check KLAR tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

Skr442.00K

SEK

Capital Expenditures

Skr33.00K

SEK

Data as of

Mar 2020

Most recent filing

Annual Capital Reinvestment Ratio for Klaria Pharma Holding AB (None–None)

Year-by-year Capital Reinvestment Ratio for Klaria Pharma Holding AB from None to None. See free cash flow generation of Klaria Pharma Holding AB to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow